跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTINA/METFORMINA PENSA 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA/METFORMINA PENSA 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA/METFORMINA PENSA 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Towa Pharmaceutical S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2022
Approval ID
e04d6a7c13e98b94
Company
Towa Pharmaceutical S.A.
Type
Standard
Approval Details
Approval Id
e04d6a7c13e98b94
Drug Cima Aemps Name
SITAGLIPTINA/METFORMINA PENSA 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
87971
Holder Company Name
Towa Pharmaceutical S.A.
Marketing Company Name
Towa Pharmaceutical S.A.
Authorization Date
2022-07-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg/1.000 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Towa Pharmaceutical S.A.
Active Ingredients
SITAGLIPTINA HIDROCLORURO MONOHIDRATO
56,69 mg
METFORMINA HIDROCLORURO
1.000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2022
Approval ID
e04d6a7c13e98b94
Type
Standard
Back to CIMA-AEMPS Approvals